Oral Tonapofylline (BG9928) in Patients With Heart Failure and Renal Insufficiency

Summary

The main purpose of this study is to determine the safety and tolerability of tonapofylline (BG9928) when given at different doses to patients with heart failure and renal insufficiency. This study will also explore: * Disease related quality-of-life * Exercise capacity * Renal function * Concomitant medications

Timeline

Start

2009-02

Primary completion

2010-01

Completion

2010-01

Outcome

Outcome not reported

Stopped: “Company Decision”

Drugs

Indications